A study published in the Medical Journal of Australia todays says the increase in the number of malignant mesothelioma cases in Western Australia over the past decade is the result of home renovation and…
Scientists have discovered a new way of controlling a hormone that stimulates cancer growth and, along the way, gained new insight into how the feel-good hormone oxytocin can be regulated. Researchers…
A “spelling mistake” in a DNA sequence can trigger a process that switches a crucial anti-cancer gene off, thereby boosting the risk of cancer developing, researchers have found. In a paper published in…
Smokers who light up within 30 minutes of waking up are 1.79 times as likely to develop lung cancer as those who have their first cigarette at least an hour after waking up, a study has found. It’s no…
Combining a new anti-cancer agent with chemotherapy has shown promise in the treatment of some of the most aggressive and difficult-to-treat forms of breast cancer, scientists have found. Around 20% of…
At last, some good news for allergy sufferers: certain allergies have been linked to a reduced risk of cancer, according to new research from Denmark. Previous studies have examined the possible links…
Women who smoke while pregnant may raise the resulting child’s risk of developing heart disease by as much as 15%, a new study has found. Smoking during pregnancy has previously been linked to fetal health…
Over 60% of Australian adults are now overweight or obese, according to a report released today by the Australian Institute of Health and Welfare. The report, Key indicators of progress for chronic disease…
Scientists have developed tiny particles capable of taking large doses of anti-cancer drugs right to a tumour’s doorstep, opening the way to a new generation of more effective treatments. Nanotechnology…
Australian researchers have shown for the first time that the number of girls presenting with pre-cancer cells on the cervix has dropped following the introduction of a wide ranging vaccination program…
A relatively new medication called olaparib can help extend remission times for ovarian cancer patients to around eight months, almost four months longer than patients on a placebo, according to clinical…